Background: Conventional transbronchial needle aspiration (TBNA) is a cheap, minimally invasive tool for lung cancer staging and diagnosis. Endobronchial ultrasound-guided TBNA (EBUS-TBNA) is more sensitive but is more expensive and less widely available. We describe a prospective analysis of TBNA diagnostic, staging and cost utility in a centre in the UK. Objectives: To illustrate the potential diagnostic, staging and cost utility of a low cost conventional TBNA service. Methods: A prospective analysis of 79 TBNA procedures over a 2-year period was performed looking at performance and cost utility in a ‘mixed’ cohort with variable pre-test probability of malignancy (year 1) followed by a high probability cohort (year 2). Results: TBNA avoided mediastinoscopy in 25% of the cases overall (37% in high probability vs. 13% in the ‘mixed’ cohort, p = 0.03). The overall prevalence of malignancy was 84%, sensitivity 79%, negative predictive value 58% and accuracy 85%. Diagnostic utility varied with pre-test probability and nodal station. TBNA down-staged 8% of lung cancer patients to receive surgery and confirmed the pre-treatment stage (inoperability) in 74%. TBNA led to theoretical cost savings of GBP 560 per patient. Conclusions: TBNA can achieve a high diagnostic sensitivity for cancer in high probability patients and stage the majority appropriately, thereby avoiding unnecessary mediastinoscopies and reducing costs. It may also down-stage a minority to have surgery. TBNA is cheap, routinely available and learnable. As EBUS-TBNA will take time to develop due to its costs, all respiratory centres should perform TBNA at flexible bronchoscopy in suspected lung cancer with accessible mediastinal adenopathy.

Keywords:
Cost analysis, Diagnosis, Lung cancer, Mediastinoscopy, Staging, Transbronchial needle aspiration
1.
Detterbeck FC, Jantz MA, Wallace M, Vansteenkiste J, Silvestri GA; American College of Chest Physicians: Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines, ed. 2. Chest 2007;132(3 suppl):202S–220S.
2.
Cetinkaya E, Yildiz P, Altin S, Yilmaz V: Diagnostic value of transbronchial needle aspiration by Wang 22-gauge cytology needle in intrathoracic lymphadenopathy. Chest 2004;125:527–531.
3.
Holty JE, Kuschner WG, Gould MK: Accuracy of transbronchial needle aspiration for mediastinal staging of non-small cell lung cancer: a meta-analysis. Thorax 2005;60:949–955.
4.
Le Jeune I, Baldwin D: Measuring the success of transbronchial needle aspiration in everyday clinical practice. Respir Med 2007;101:670–675.
5.
Hermens FH, Limonard GJ, Termeer R, van den Berg W, Visser FJ, Hol BE, Janssen JP: Learning curve of conventional transbronchial needle aspiration in pulmonologists experienced in bronchoscopy. Respiration 2008;75:189–192.
6.
Bernasconi M, Chhajed PN, Muller P, Borer H: Patients’ satisfaction with flexible bronchoscopy in a hospital-based community practice. Respiration 2009;78:440–445. DOI: 10.1159/000228906.
7.
Patel NM, Pohlman A, Husain A, Noth I, Hall JB, Kress JP: Conventional transbronchial needle aspiration decreases the rate of surgical sampling of intrathoracic lymphadenopathy. Chest 2007;131:773–778.
8.
Kunst PW, Lee P, Paul MA, Senan S, Smit EF: Restaging of mediastinal nodes with transbronchial needle aspiration after induction chemoradiation for locally advanced non-small cell lung cancer. J Thorac Oncol 2007;2:912–915.
9.
Bilaceroglu S, Chhajed P, Ahmet M, Aydogdu Z, Cagirici U: Computed tomography-guided transthoracic needle aspiration in diagnosing and staging hilar and mediastinal masses of lung cancer after negative bronchoscopy. J Bronchol 2007;14:149–155.
10.
Yasufuku K, Chiyo M, Koh E, Moriya Y, Iyoda A, Sekine Y, Shibuya K, Iizasa T, Fujisawa T: Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancer. Lung Cancer 2005;50:347–354.
11.
Piet AH, Lagerwaard FJ, Kunst PW, van Sornsen de Koste JR, Slotman BJ, Senan S: Can mediastinal nodal mobility explain the low yield rates for transbronchial needle aspiration without real-time imaging? Chest 2007;131:1783–1787.
12.
van Sornsen de Koste JR, Lagerwaard FJ, Nijssen-Visser MR, Schuchhard-Schipper R, Joosten H, Senan S: What margins are necessary for incorporating mediastinal nodal mobility into involved-field radiotherapy for lung cancer? Int J Rad Oncol Biol Phys 2002;53:1211–1215.
13.
Jenkins P, Salmon C, Mannion C: Analysis of the movement of calcified lymph nodes during breathing. Int J Rad Oncol Biol Phys 2005;61:329–334.
14.
Senan S, De Ruysscher D, Giraud P, Mirimanoff R, Budach V: Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer. Radiother Oncol 2004;71:139–146.
15.
Rodriguez de Castro F, Diaz Lopez F, Serda GJ, Lopez AR, Gilart JF, Cabrera Navarro P: Relevance of training in transbronchial fine-needle aspiration technique. Chest 1997;111:103–105.
16.
Hsu LH, Liu CC, Ko JS: Education and experience improve the performance of transbronchial needle aspiration: a learning curve at a cancer center. Chest 2004;125:532–540.
17.
Diacon AH, Schuurmans MM, Theron J, Brundyn K, Louw M, Wright CA, Bolliger CT: Transbronchial needle aspirates: how many passes per target site? Eur Respir J 2007;29:112–116.
18.
Smyth CM, Stead RJ: Survey of flexible fibreoptic bronchoscopy in the United Kingdom. Eur Respir J 2002;19:458–463.
19.
Bilaceroglu S, Chhajed P: Transbronchial needle aspiration: a diagnostic tool in routine bronchoscopy. J Assoc Physicians India 2005;53:797–802.
20.
Bilaceroglu S, Cagiotariotaciota U, Gunel O, Bayol U, Perim K: Comparison of rigid and flexible transbronchial needle aspiration in the staging of bronchogenic carcinoma. Respiration 1998;65:441–449.
21.
Trisolini R, Agli LL, Cancellieri A, Poletti V, Tinelli C, Baruzzi G, Patelli M: The value of flexible transbronchial needle aspiration in the diagnosis of stage I sarcoidosis. Chest 2003;124:2126–2130.
22.
Department of Health 2002: Reforming NHS financial flows: introducing Payment by Results. London, DOH, 2002.
23.
Department of Health: Payment by Results: Tariff Information 2007–2008. www.dh.gov.uk/en/Managingyourorganisation/Financeandplanning/NHSFinancialReforms/DH_077279 (accessed December 2, 2009).
24.
De Leyn P, Lardinois D, Van Schil PE, Rami-Porta R, Passlick B, Zielinski M, Waller DA, Lerut T, Weder W: ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. Eur J Cardiothorac Surg 2007;32:1–8.
25.
Trisolini R, Tinelli C, Cancellieri A, Paioli D, Alifano M, Boaron M, Patelli M: Transbronchial needle aspiration in sarcoidosis: yield and predictors of a positive aspirate. J Thor Cardiovasc Surg 2008;135:837–842.
26.
Bilaceroglu S, Gunel O, Eris N, Cagirici U, Mehta AC: Transbronchial needle aspiration in diagnosing intrathoracic tuberculous lymphadenitis. Chest 2004;126:259–267.
27.
Diacon AH, Schuurmans MM, Theron J, Louw M, Wright CA, Brundyn K, Bolliger CT: Utility of rapid on-site evaluation of transbronchial needle aspirates. Respiration 2005;72:182–188.
28.
Schenk DA, Chambers SL, Derdak S, Komadina KH, Pickard JS, Strollo PJ, Lewis RE, Patefield AJ, Henderson JH, Tomski SM, et al: Comparison of the Wang 19-gauge and 22-gauge needles in the mediastinal staging of lung cancer. Amer Rev Respir Dis 1993;147:1251–1258.
29.
Silvestri GA, Gould MK, Margolis ML, Tanoue LT, McCrory D, Toloza E, Detterbeck F; American College of Chest Physicians: Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines, ed 2. Chest 2007;132(3 suppl):178S-201S.
30.
Shah PL, Singh S, Bower M, Livni N, Padley S, Nicholson AG: The role of transbronchial fine needle aspiration in an integrated care pathway for the assessment of patients with suspected lung cancer. J Thorac Oncol 2006;1:324–327.
31.
Win T, Stewart S, Groves AM, Pepke-Zaba J, Laroche CM: The role of transbronchial needle aspiration in the diagnosis of bronchogenic carcinoma. Respir Care 2003;48:602–605.
32.
Medford AR, Agrawal S, Free CM, Bennett JA: Mediastinal staging procedures in lung cancer: EBUS, TBNA and mediastinoscopy. Curr Opin Pulm Med 2009;15:334–342.
33.
Audit Commission: PbR Data Assurance Framework 2007/08: findings from the first year of the national clinical coding audit programme. www.audit-commission.gov.uk/nationalstudies/health/pbr/Pages/pbrdataassuranceframework200708.aspx (accessed December 2, 2009).
34.
Medford AR: Endobronchial ultrasound-transbronchial needle aspiration and lung cancer. J R Coll Physicians Edinb 2009;39:91.
35.
Medford AR, Agrawal S, Free CM, Bennett JA: Retrospective analysis of Healthcare Resource Group coding allocation for local anaesthetic video-assisted ‘medical’ thoracoscopy in a UK tertiary respiratory centre. QJM 2009;102:329–333.
36.
Medford AR, Agrawal S, Free CM, Bennett JA: A performance and theoretical cost analysis of endobronchial ultrasound-guided transbronchial needle aspiration in a UK tertiary respiratory centre. QJM 2009;102:859–864. DOI: 10.1093/qjmed/hcp136.
37.
Puhakka HJ: Complications of mediastinoscopy. J Laryng Otol 1989;103:312–315.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.